Demo Day 2016: Frying nerves to treat high blood pressure
Channel: UNeMed Corporation
Date: 24/10/2016

When an $800 million clinical trial recently failed at Medtronic, few understood why. Except for a talented group of researchers at UNMC, who not only understood the problem but also developed the solution: A platform technology that non-invasively measures the neural signals that regulate blood flow. The technology could be applied to high blood pressure, blood loss, and neurodegenerative disease. 

Peter Ricci Pellegrino, Ph.D., of the University of Nebraska Medical Center presents "Sympathetic Vasomotion."